
An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Features for The Treatment of Coronaviral & Adenoviral Infections (NOVIR ) NOVIR
From Mas Pharmaceuticals
An Antiviral Formulation Consisting of 3 Protopanaxatriol-Class Glucopyranoside Analouges , A Semi-Synthetic Flavonol Glycoside Derivative and an Immuno-Modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & Adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA…
Metadata quality:
Data description filled
Files documentation missing
License filled
Update frequency not followed
File formats are closed
Temporal coverage not set
Spatial coverage not set
All files are available
Updated on April 21, 2020